Kyn Therapeutics Strengthens Leadership Team with Key Appointments
BOSTON--(BUSINESS WIRE)--Kyn Therapeutics, a clinical-stage biotechnology company developing highly differentiated cancer immunotherapies, today announced the appointment of Jeffrey Ecsedy, Ph.D.,...